GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

OMN6   Click here for help

GtoPdb Ligand ID: 14120

Compound class: Peptide
Comment: OMN6 is a cyclic antimicrobial peptide based on the sequence of cecropin A, with activity against drug-resistant Gram-negative bacteria [1].
No information available.
Summary of Clinical Use Click here for help
OMN6 has advanced to clinical evaluation as a treatment for hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) caused by Acinetobacter Baumannii complex. A Phase 2 trial (NCT06087536) has begun recruitment (last update February 2025).
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT06087536 A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex Phase 2 Interventional Omnix Medical Ltd